What is Triple Negative Breast Cancer?

Triple-negative breast cancer is a distinct type of breast cancer that accounts for about 10% to 15% of all cases. It differs from other forms because it does not have estrogen, progesterone, or HER2 receptors, which are commonly targeted in standard breast cancer treatments. Since these receptors are absent, hormone therapies and HER2-targeted drugs are not effective, requiring a different approach to care.

As understanding of this cancer has grown, treatment strategies have evolved. Research continues to expand available options and improve patient outcomes. In this blog, we will discuss the symptoms, explain the different subtypes, and discuss the treatment approaches available to patients today.

What Is Triple-Negative Breast Cancer?

Triple-negative breast cancer is identified through laboratory testing that shows the tumour does not depend on hormone or HER2 signalling for growth. This diagnosis is confirmed when pathology tests for all three receptors return negative. Because it is not driven by these common pathways, the cancer behaves differently from hormone-related breast cancers and follows a distinct biological pattern. It often grows more quickly, but its high cellular activity can make it particularly responsive to chemotherapy.

What Are the Types of Triple-Negative Breast Cancer?

Triple-negative breast cancer is not a single disease. It includes several subtypes that differ in how they grow, spread, and respond to treatment. Identifying the subtype helps guide treatment decisions and may influence outcomes.

Basal-Like Triple-Negative Breast Cancer

Basal-like is the most common subtype of triple-negative breast cancer. These tumours resemble basal cells found in the breast ducts and are often associated with BRCA1 gene mutations. They tend to grow quickly and are more frequently diagnosed in younger women.

Immunomodulatory Triple-Negative Breast Cancer

This subtype is closely linked to the immune system. The tumours are often surrounded by immune cells and interact actively with the body’s defence mechanisms. Because of this immune involvement, treatments that stimulate or support the immune response may be particularly effective.

Mesenchymal Triple-Negative Breast Cancer

Mesenchymal tumours are composed of cells that resemble connective or muscle tissue. They are known for their ability to move and invade surrounding areas, which can increase the risk of spread to other parts of the body. This subtype often shows aggressive behaviour.

Luminal Androgen Receptor (LAR) Triple-Negative Breast Cancer

The luminal androgen receptor subtype is distinct because it expresses androgen receptors, despite lacking estrogen and progesterone receptors. These tumours usually grow more slowly than other triple-negative subtypes and may respond to therapies that target androgen signalling.

What Are the Symptoms of Triple-Negative Breast Cancer?

Early recognition of symptoms is important, as triple-negative breast cancer can grow more quickly than some other types. Changes may appear between routine screenings, which makes regular self-checks especially valuable. You should contact a healthcare provider if you notice any of the following signs.

• A new breast lump or mass: This is the most common symptom. The lump is often hard, has irregular edges, and may or may not be painful.
• Breast or nipple pain: Although many breast cancers do not cause pain, persistent or unexplained discomfort should be evaluated.
• Dimpling or thickening of the breast skin: The skin may take on a pitted appearance, similar to an orange peel, due to changes in the underlying tissue.
• Nipple discharge: Any fluid leaking from the nipple when not breastfeeding, especially if clear or bloody, should be checked.
• Nipple retraction: A nipple that turns inward when it previously pointed outward can be a warning sign.
• Changes in nipple or breast skin: Redness, flaking, dryness, or thickened skin may resemble a rash or infection, but should not be ignored.
• Swelling in part or all of the breast: One breast may appear larger or feel heavier, even if no lump is felt.
• Swollen lymph nodes: Lumps may be felt under the arm or near the collarbone, which can indicate spread to nearby lymph nodes.

What Are The Causes And Key Factors?

The exact cause of triple-negative breast cancer is not fully understood. Like other cancers, it develops when changes occur in the DNA of breast cells, causing uncontrolled growth. Genetic mutations play a major role, especially changes in the BRCA1 and BRCA2 genes. These genes normally help repair damaged DNA, but when they do not function properly, the risk of cancer increases.

Research has also identified several patterns among people who are more likely to develop triple-negative breast cancer. These patterns point to specific factors that can increase risk.

Key Factors

• Age: Triple-negative breast cancer is more often diagnosed in women under the age of 50, unlike many other breast cancer types.
• Race and ethnicity: African American and Hispanic women are diagnosed with this subtype more frequently, though the exact reasons are still under investigation.
• Family and personal history: A family history of breast cancer, particularly in close relatives, raises risk. Having had breast cancer previously also increases the likelihood of developing it again.
• Lifestyle and reproductive factors: Obesity, especially after menopause, and low physical activity are linked to a higher risk. Long-term use of birth control pills has also been associated with increased risk.
• Environmental exposure: Radiation treatment to the chest at a young age, such as therapy for Hodgkin lymphoma, can raise the risk later in life.

How Is Triple-Negative Breast Cancer Diagnosed?

Diagnosis involves a series of tests that help locate the tumour and determine its characteristics. Doctors rely on imaging studies and tissue analysis to confirm the presence of cancer and identify its specific type.

• Clinical breast exam: A doctor or nurse examines the breasts and underarms to check for lumps, thickening, or other abnormalities, noting their size and texture.
• Mammogram: A low-dose X-ray of the breast used to detect tumours that may be too small to feel. It is a standard tool for breast cancer screening.
• Breast ultrasound: Uses sound waves to create images of breast tissue. It helps distinguish solid masses from fluid-filled cysts and is especially useful in dense breast tissue.
• Breast MRI: Uses magnetic fields and radio waves to produce detailed images of the breast. It is often used to assess the size of the tumour and determine whether cancer has spread within the breast.
• Biopsy: The definitive step in diagnosis. A small sample of tissue is removed and examined in a laboratory to confirm cancer and test for hormone and HER2 receptors, which establishes whether the cancer is triple-negative.

Stages of Triple-Negative Breast Cancer

After imaging tests and a biopsy confirm triple-negative breast cancer, doctors take the next step of determining its stage. Staging explains how large the tumour is and whether the cancer has spread beyond the breast. This step is essential because it guides treatment decisions and helps doctors plan the most effective approach to care.

• Stage I: The cancer is small and limited to the breast tissue, with no spread to nearby lymph nodes.
• Stage II: The tumour is larger or has spread to a small number of lymph nodes under the arm.
• Stage III: The cancer is more advanced, with a larger tumour or spread to several lymph nodes or nearby tissues such as the skin or chest wall.
• Stage IV: The cancer has spread to distant organs, including the lungs, liver, or bones. This is known as metastatic disease.

How Is Triple-Negative Breast Cancer Treated?

Treatment for triple-negative breast cancer is tailored to how advanced the disease is and how the tumour behaves. Because these cancer cells tend to grow and divide quickly, treatment often involves a combination of approaches designed to remove the tumour and destroy any remaining cancer cells.

Surgery

• Lumpectomy: Also known as breast-conserving surgery, this procedure removes the tumour along with a small margin of healthy tissue.
• Mastectomy: Removal of the entire breast may be recommended if the tumour is large or if multiple areas of cancer are present.
• Oncoplastic surgery: Combines cancer removal with reconstructive techniques to preserve the appearance of the breast.
• Sentinel lymph node biopsy: Involves removing the first lymph nodes most likely to be affected, helping determine whether the cancer has spread.

Medical Treatments

• Chemotherapy: The cornerstone of treatment for triple-negative breast cancer. It uses drugs to destroy fast-growing cancer cells and is often given before surgery to shrink the tumour.
• Targeted therapy: These treatments focus on specific features of cancer cells, allowing for more precise treatment with less impact on healthy cells.
• Immunotherapy: Helps the immune system recognise and attack cancer cells, making the body’s natural defences more effective.

Radiation Therapy

Radiation therapy uses high-energy beams to destroy remaining cancer cells after surgery. It is directed at the area where the tumour was removed to reduce the risk of recurrence.

Conclusion

Managing a diagnosis of triple-negative breast cancer can be challenging, but advances in medical care continue to improve treatment outcomes. Early detection and timely intervention remain critical, and with the right combination of surgery and medical therapies, many people can move forward with confidence. Strong support from family and an experienced medical team plays an essential role throughout this journey.

India is widely recognised for its advanced cancer care, offering high-quality treatment at significantly lower costs than in many other countries. This is why many NRIs choose to return to India for specialised medical care. Planning is key, and Niva Bupa NRI Health Insurance provides comprehensive coverage for critical illnesses and hospitalisation. With a reliable insurance partner in place, you can focus fully on treatment and recovery, without the added stress of managing medical expenses.

FAQs

1. How fast does this cancer grow?

   This type grows faster than most other breast cancers. It can sometimes appear between yearly mammograms. This is why checking for lumps every month is so important.

2. Will my hair grow back after chemotherapy?

   Yes. Hair loss is a common side effect of the drugs used for this cancer. Most people see their hair start to grow back a few months after the final treatment. The texture might be different at first.

3. Is genetic testing mandatory?

   It is not mandatory. However, many doctors strongly recommend it for this specific cancer. The results can change your treatment plan. It also provides important information for your children or siblings.

4. How does this cancer affect bone health?

   Some treatments can weaken your bones. Doctors might monitor your bone density. They may suggest calcium supplements. They might suggest Vitamin D to keep your bones strong.